首页 | 本学科首页   官方微博 | 高级检索  
     


Taiwan consensus of pharmacological treatment for bipolar disorder
Authors:Ya-Mei Bai  Ching-Jui Chang  Shang-Ying Tsai  Yi-Chyan Chen  Mei-Chun Hsiao  Cheng-Ta Li  Peichi Tu  Shang-Wen Chang  Winston W. Shen  Tung-Ping Su
Affiliation:1. Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan, ROC;2. Division of Psychiatry, Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan, ROC;3. Department of Psychiatry, Cathay General Hospital, Taipei, Taiwan, ROC;4. Department of Psychiatry, College of Medicine, National Taiwan University, Taipei, Taiwan, ROC;5. Department of Psychiatry, School of Medicine, Taipei Medical University, Taipei, Taiwan, ROC;6. Department of Psychiatry, Taipei Medical University Hospital, Taipei, Taiwan, ROC;7. Department of Psychiatry, Buddhist Tzu Chi General Hospital, Taipei Branch, Taipei, Taiwan, ROC;8. Department of Psychiatry, Chang-Gung Hospital Keelung and Chang-Gung University School of Medicine, Taoyuan, Taiwan, ROC;9. Department of Medical Research and Education, Taipei Veterans General Hospital, Taipei, Taiwan, ROC;10. Institute of Neuroscience, School of Life Sciences, National Yang-Ming University, Taipei, Taiwan, ROC;11. Department of Psychiatry, Shin Kong Wu Ho Su Memorial Hospital, Taipei, Taiwan, ROC;12. Community Medicine Research Center and Institute of Public Health, National Yang-Ming University, Taipei, Taiwan, ROC;13. Department of Psychiatry, Taipei Medical University–Wan Fang Hospital, Taipei, Taiwan, ROC
Abstract:Bipolar disorder is an important psychiatric disorder with different disease phases. The pharmacological treatment is complicated, and is updated frequently as new research evidence emerges. For the purpose of international collaboration, research, and education, the Taiwan consensus of pharmacological treatment for bipolar disorders was initiated by the Taiwanese Society of Biological Psychiatry and Neuropsychopharmacology (TSBPN) – the Bipolar Chapter, which was established in August 2010 and approved as a member of International Society of Bipolar Disorder. TSBPN is the country member of the World Federation of Societies of Biological Psychiatry (WFSBP). The development of the Taiwan consensus for bipolar disorder was mainly based on the template of WFSBP Guidelines, with references to other international guidelines including the Canadian Network for Mood and Anxiety Treatments, and British Association for Psychopharmacology. We have also added Taiwanese experts’ experience, Taiwan national health insurance data, and the indications for the pharmacological treatment of bipolar disorder given by the Taiwan Department of Health, to emphasize the balance between efficacy and safety, and to make this consensus a concise, empirical, and important reference for clinical psychiatric practice.
Keywords:bipolar disorder  consensus  pharmacotherapy  Taiwan
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号